| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47503c536a471264a5fda6544bd10bfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_930c0d714758369d228906540e8bd456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24d41624f4c12622605b7048517fe8f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f50ae25c9624fb676e8436dc6add9bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd63d2e378504b19793f9b2631a8972 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f41c705307ddc904238ea16fbb9d727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb9aeb7613a236c9da046529a5f52f78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_476c3bb00a05ca16fe6fb8fb15e2456a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf566b5dafd02094c5a0c635bd3fe811 |
| publicationDate |
2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012012264-A1 |
| titleOfInvention |
Methods and compositions for the treatment of allergy |
| abstract |
The present invention relates to compositions comprising an antagonist of the histamine H1 receptor and a compatible antagonist of the histamine H4 receptor. The antagonist compounds are selected to prevent the H4 receptor antagonist from interfering with the H1 receptor antagonist's suppression of acute phase allergic responses in a patient. The present invention also relates to compositions comprising a mast cell stabilizer and a compatible antagonist of the histamine H4 receptor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3807282-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014033480-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11498929-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112204032-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3037094-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11584763-B2 |
| priorityDate |
2010-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |